Compile Data Set for Download or QSAR
Report error Found 22 Enz. Inhib. hit(s) with all data for entry = 1464
TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324417(US10189835, Compound 595)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324427(US10189835, Compound 937)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324426(US10189835, Compound 912)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324425(US10189835, Compound 910)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324424(US10189835, Compound 828)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324424(US10189835, Compound 828)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324423(US10189835, Compound 699)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324422(US10189835, Compound 698)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324421(US10189835, Compound 697)
Affinity DataEC50: <1.00E+3nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324419(US10189835, Compound 695)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324418(US10189835, Compound 600)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324403(US10189835, Compound 434)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324416(US10189835, Compound 594)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324415(US10189835, Compound 805)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324413(US10189835, Compound 803)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324412(US10189835, Compound 800)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324411(US10189835, Compound 798)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324410(US10189835, Compound 796)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324409(US10189835, Compound 795)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324408(US10189835, Compound 599)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324406(US10189835, Compound 587)
Affinity DataEC50: <1.00E+3nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324405(US10189835, Compound 561)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent